Dissecting the impact of early life adversity on psychiatric disorders in the human brain at cell-specific levels

This project aims to investigate the impact of early life adversity on psychiatric disorders in the human brain using single-cell RNA sequencing. I will be traveling to the lab of Dr. Elisabeth Binder at the Max Planck Institute for Psychiatry in Germany. Dr. Binder is a leading researcher in the field of translational psychiatry, with immense expertise in studying early life adversity and mental illness using molecular approaches. This work will advance our understanding of how early life adversity contributes to long-lasting changes in the brain and psychiatric disorders at cell-specific levels. Overall, this research could provide novel insights into the complex interactions of genetics and environmental factors, as well as the molecular mechanisms underlying psychiatric disorders. Through this research activity, I will gain strong expertise and knowledge in early life adversity research and bioinformatic analysis. Additionally, I will have the opportunity to bring these advanced skills back to my lab at McGill University, where I will share knowledge and mentor students.

Faculty Supervisor:

Gustavo Turecki

Student:

Partner:

Max-Planck-Institut für Psychiatrie

Discipline:

Life Sciences

Sector:

Health and Related Sciences & Technology

University:

McGill University

Program: